title: Hematuria in a patient with class IV lupus nephritis.
authors.affiliation: Renal Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. bmittal@partners.org
authors.forename: B V
authors.initials: BV
authors.lastname: Mittal
authors.forename: S
authors.initials: S
authors.lastname: Pendse
authors.forename: H G
authors.initials: HG
authors.lastname: Rennke
authors.forename: A K
authors.initials: AK
authors.lastname: Singh
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D001706:Biopsy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004544:El Salvador / Q000208:ethnology; D005260:Female; D005500:Follow-Up Studies; D050533:Glomerular Basement Membrane / Q000473:pathology / Q000648:ultrastructure; D005920:Glomerular Mesangium / Q000473:pathology / Q000648:ultrastructure; D005938:Glucocorticoids / Q000627:therapeutic use; D006417:Hematuria / Q000209:etiology*; D006630:Hispanic or Latino; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006886:Hydroxychloroquine / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007678:Kidney Glomerulus / Q000473:pathology / Q000648:ultrastructure; D017706:Lisinopril / Q000627:therapeutic use; D008181:Lupus Nephritis / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology*; D008875:Middle Aged; D009543:Nifedipine / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D013777:Tetrazoles / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome; D014633:Valine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000068756:Valsartan
chemical_list: D000959:Antihypertensive Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D013777:Tetrazoles; D006852:Hydrochlorothiazide; D006886:Hydroxychloroquine; D000068756:Valsartan; D003520:Cyclophosphamide; D017706:Lisinopril; D014633:Valine; D009543:Nifedipine; D011241:Prednisone